FC2ブログ

バイオの戯言

ライフサイエンスに関する話題についてコメント(戯言?)を述べていくブログです。

【プレスリリースメモ】 RNAi関係 (2013.1.27)  

<Antisense Therapeutics>
Appendix 4C Quarterly(2013.1.14)
ATL1103 Phase II trial - patient enrolment commences(2013.1.24)

<Arrowhead Research>
Arrowhead Research Corporation Announces Proposed Public Offering of Common Stock and Warrants(2013.1.24)
Arrowhead Announces Pricing of a Public Offering of Common Stock and Warrants(2013.1.25)

<EnGeneIC Ltd>
ENGENEIC HAS RECENTLY COMPLETED A PHASE I FIRST-IN-MAN CLINICAL TRIAL WHICH PROVED THE SAFETY OF ITS EDV TECHNOLOGY(2013.1)

<Generex Biotechnology>
Generex Oral-lyn™ Phase III Dossier Submitted To Indian Government For Marketing Approval(2013.1.23)

<Gene Signal>
Gene Signal announces completion of private funding round Company set to embark on aggressive three-year clinical and commercialisation plan for angiogenesis therapies(2013.1.23)

<iCo Therapeutics>
iCo Therapeutics Grants Options to Directors, Officers and Employees(2013.1.22)

<Lorus Therapeutics>
Lorus Therapeutics Announces Issuance of United States Patent for Cancer Therapy IL-17E(2013.1.22)

<Mirna Therapeutics>
Mirna Therapeutics Presents Preclinical Data on Lead Product Candidate MRX34 at Keystone Conference(2013.1.23)

<OPKO Health>
OPKO Announces Proposed Private Offering of $150 Million Convertible Senior Notes Due 2033(2013.1.23)
OPKO Prices Offering of $175 Million of 3.00% Convertible Senior Notes Due 2033(2013.1.25)

<Pharmaxis>
Conference Call Details(2013.1.22)
Recording of Investor Conference Call 24 January 2013(2013.1.24)


スポンサーサイト
[ 2013/01/27 12:39 ] プレスリリース | TB(0) | CM(0)
コメントの投稿













管理者にだけ表示を許可する
最新ニュース
お気に入り
カレンダー(月別)
07 ≪│2018/08│≫ 09
- - - 1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31 -
特選品
特許関係の書籍-3
特許関係の書籍-2
特許関係の書籍-1
情報関係の書籍
月別アーカイブ
プロフィール

のぐひで

Author:のぐひで
FC2ブログへようこそ!